MedPath

40-301 : Special Drug Use-Results Survey of ADLUMIZ

Not Applicable
Conditions
Cancer cachexia: non-small cell lung cancer, gastric cancer, pancreatic cancer, large intestine canc
Registration Number
JPRN-jRCT2011210014
Lead Sponsor
Kuro Toshihiko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
5000
Inclusion Criteria

All patients with (Cancer cachexia: non-small cell lung cancer, gastric cancer, pancreatic cancer, large intestine cancer) for whom ADLUMIZ is administered

Exclusion Criteria

patients who have not received ADLUMIZ

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath